Neumora Therapeutics, Inc. (NMRA): Strong Buy with 1,000% Upside Potential
Neumora Therapeutics, Inc. (NMRA) Neumora Therapeutics, Inc. has caught the attention of analysts, who have rated the stock as a “Strong Buy”…
Browse research
Author: STA Research
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
3M Company: Analyst Insights, Stock Performance & Bearish Fundamentals
3M Company (MMM) RBC Capital Markets (Analyst Rank#3) recently adjusted its target price for 3M Company, lowering it from USD 100 to…
Market Analysis & Stock News: January 3rd, 2024
Global Market Update Canadian Markets: Canada’s TSX rose, driven by gains in energy stocks as oil prices continued their upward momentum. Investors…
Top Trending Analyst Ratings: January 3rd, 2025
Top Ratings These are today’s “Top Analyst Ratings” for Friday January 3rd, 2025 AIG (American International Group) (AIG): J.P. Morgan Chase &…
Market Analysis & Stock News: January 2nd 2025
Global Market Update Canadian Markets Canada’s main stock index finished the first trading day of the year on a positive note, driven…